Thrombosis
📧 Sign up to get email alerts when something new happens for Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter
A single-center post-market study evaluating thrombolytic therapy using the Versus Catheter has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-03Clinical Trial Update: Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
The AXAES trial evaluating correlation between LR-ACT and anti-Xa activity during endovascular procedures was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-10-11Clinical Trial Update: Perioperative Bleeding and Aspirin Use in Spine Surgery [Phase 3]
A Phase 3 clinical trial evaluating perioperative bleeding and aspirin use in spine surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-15Clinical Trial Update: Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates [NA]
A trial comparing heparin versus no heparin for PICC patency in premature neonates has been withdrawn.
-
EMA withdrawal · 2009-04-23Teva Pharma B.V. withdraws its marketing authorisation application for Clopidogrel Teva Pharma (clopidogrel hydrobromide)
Teva Pharma B.V. has withdrawn its marketing authorisation application for Clopidogrel Teva Pharma (clopidogrel hydrobromide).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.